Search
for
Sort by
Research 481–510 of 1000+
- Long-term consequences of critical illness
- Cutaneous complications of chemotherapeutic agents
- Clinical utility and validity of minoxidil response testing in androgenetic alopecia
- Letter: Platelet-Rich Plasma for Treating Male Pattern Baldness
- Topical and intralesional therapies for alopecia areata
- Laser therapy on darker ethnic skin
- Intralesional therapy for the treatment of keratoacanthoma
- Minoxidil
- Severe Urticaria After Laser Treatment for Hair Reduction
- Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: A randomized, placebo‐controlled trial
- Eccema dishidrótico palmoplantar asociado a secukinumab
- Glucocorticoid and Sex Hormone Receptors: Clinical Implications and Therapeutic Relevance
- Spironolactone treatment of porphyria cutanea tarda-associated hirsutism
- Topical imiquimod—Be aware of the unexpected
- Ponatinib-induced pityriasis rubra pilaris-like adnexal dysmaturation: A case report
- Imiquimod
- Calcipotriene/betamethasone in the treatment of psoriasis: a review article
- Acquired Localized Hypertrichosis Induced by Rivastigmine
- Results of low‐level laser therapy in the treatment of hair growth: An Egyptian experience
- Step-down approach to concentration of intra-lesional triamcinolone acetonide in treatment of scalp patchy alopecia areata: insights from an open-label randomized trial
- Real-world evidence in alopecia areata treatment: A narrative review
- Safety and use of oral minoxidil in pediatric patients: a systematic review and meta-analysis
- Randomized controlled trial on the efficacy and safety of the combination therapy of topical 0.1% finasteride − 5% Minoxidil in male androgenetic alopecia
- The Potential of <i>Cyperus rotundus</i> L. As a Natural Hair Removal Agent: A Review of Traditional and Modern Applications
- Efficacy and Safety of Baricitinib in Patients With Alopecia Areata: A Real‐World Cohort Study
- The Effectiveness and Safety of Three Treatment Regimens of Topical Minoxidil 5.0%, Betamethasone 0.064% w/w, and Castor and Jojoba Oils for Alopecia Areata: A Multicenter Cohort Study
- Common Causes of Hair Loss and Their Treatment Options
- Female pattern hair loss: therapeutic update
- Comparative study between topical methotrexate 1% gel and minoxidil 5% gel in the treatment of localized alopecia areata
- Mucocutaneous reactions to chemotherapy